Arcutis Biotherapeutics Inc Stock (ARQT) Forecast
The Arcutis Biotherapeutics Inc (ARQT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $23.12, representing a -14.39% decrease from the current price of $27.00. The highest analyst price target is $26.23, and the lowest is $20.00.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ARQT Price Target
Average 26.47 (-1.97% Downside)
Is Arcutis Biotherapeutics Inc (ARQT) A Buy Now?
Oscillators
Buy: 1 · Sell: 2 · Neutral: 4Summary: Neutral
Moving Averages
Buy: 4 · Sell: 6 · Neutral: 0Summary: Sell
According to our latest analysis, ARQT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ARQT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.05 indicates that ARQT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 48.40 indicates that ARQT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 66.71 indicates that ARQT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 34.40 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of -95.83 indicates that ARQT is still oversold but not to an extreme extent.
Long-term ARQT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Arcutis Biotherapeutics Inc financial reports and earnings history, Arcutis Biotherapeutics Inc (ARQT) stock could reach $24.63 by 2030, $32.93 by 2040 and $57.75 by 2050. See the projected annual prices until 2050 of the Arcutis Biotherapeutics Inc stock below:
- Arcutis Biotherapeutics Inc (ARQT) is expected to reach an average price of $25.99 in 2035, with a high prediction of $27.07 and a low estimate of $16.13. This indicates an -3.76% change from the last recorded price of $27.00.
- Arcutis Biotherapeutics Inc (ARQT) stock is projected to chart a bullish course in 2040, with an average price target of $27.83, representing an +3.07% change from its current level. The forecast ranges from a conservative $21.16 to a sky-high $32.93.
- Our analysts predict Arcutis Biotherapeutics Inc (ARQT) to change +12.48% by 2045, soaring from $29.71 to an average price of $30.37, potentially reaching $43.59. While $29.71 is the low estimate, the potential upside is significant.
- Arcutis Biotherapeutics Inc (ARQT) stock is expected to climb by 2050, reaching an average of $46.73, a +73.09% change from its current level. However, a wide range of estimates exists, with high and low targets of $57.75 and $43.75, respectively, highlighting the market's uncertainty.
Arcutis Biotherapeutics Inc Stock (ARQT) Year by Year Forecast
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2026
The predicted value for Arcutis Biotherapeutics Inc (ARQT) in 2026 is set at an average of $25.37. Estimates vary from a peak of $34.80 to a trough of $19.30, indicating an -6.03% surge from the present price of $27.00.
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Arcutis Biotherapeutics Inc (ARQT) is $25.43, with a high forecast of $33.47 and a low forecast of $19.46. This indicates an -5.80% decrease from the last price of $27.00.
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2028
In 2028, Arcutis Biotherapeutics Inc (ARQT) is projected to reach an average price of $18.22, with a high projection of $26.25 and a low estimate of $11.69. This indicates an -32.52% fall from the last price of $27.00.
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2029
The 2029 price forecast for Arcutis Biotherapeutics Inc Stock (ARQT) is $13.30 on average, with a high prediction of $19.76 and a low estimate of $8.23. This represents an -50.74% decrease from the previous price of $27.00.
Arcutis Biotherapeutics Inc Stock (ARQT) Price Forecast for 2030
Arcutis Biotherapeutics Inc Stock (ARQT) is expected to reach an average price of $19.66 in 2030, with a high forecast of $24.63 and a low forecast of $14.79. This signifies an -27.19% decrease from the last price of $27.00.
